Skip to main content
ILMN logo
ILMN
(NASDAQ)
Illumina, Inc.
$141.68-- (--)
Loading... - Market loading

Illumina (ILMN) Stock Price & Financial Analysis

Illumina Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$138.06 - $143.86
52-Week High$155.53
52-Week Low$77.50
Open$141.46
Volume1.75M
Average Volume (3M)1.61M
Market Cap21.95B
Shares Outstanding154.00M
P/E Ratio (TTM)25.73
Price to Sales (P/S)5.00
Price to Book (P/B)8.20
EV/EBITDA15.66
Revenue (TTM)4.39B
Net Income (TTM)853.00M
Free Cash Flow (TTM)989.00M
EPS (TTM)$5.50
Profit Margin19.42%
Operating Margin20.62%
Return on Equity (ROE)31.88%
Debt to Equity0.56
50-Day MA$128.09
200-Day MA$119.43
52-Week Change74.71%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Illumina

What is the current stock price for ILMN?

As of the latest trading session, ILMN stock trades at $142.54. The 52-week range is $77.50–$155.53, with a day range of $138.06–$143.86.

What is the P/E ratio for ILMN?

Illumina's trailing P/E ratio is 25.7, meaning investors pay $25.7 for every $1 of annual earnings. Illumina operates in the Healthcare sector.

Does ILMN pay dividends?

Illumina does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ILMN?

Analyst ratings and recommendations for ILMN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ILMN?

Illumina's market capitalization is $21.95B, classifying it as a large-cap company. Illumina operates in the Healthcare sector within the Diagnostics & Research industry.